Bayer

U.S. Food and Drug Administration Grants Priority Review for HYRNUO as First-Line Treatment for HER2-Mutated Non-Small Cell Lung Cancer

U.S. FDA Grants Priority Review to Supplemental New Drug Application for HYRNUO® (sevabertinib) Under Investigation as a First-Line Treatment of HER2-Mutated Non-Small Cell Lung Cancer Bayer announced that the U.S. Food and Drug Administration (FDA) has granted HYRNUO® (sevabertinib) Priority Review status for…

Read MoreU.S. Food and Drug Administration Grants Priority Review for HYRNUO as First-Line Treatment for HER2-Mutated Non-Small Cell Lung Cancer
Turn Therapeutics Appoints Former FDA

Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical and Regulatory Lead

Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead Turn Therapeutics Inc. a clinical-stage biotechnology company developing targeted, localized therapies for inflammatory skin diseases, announced the appointment of Stephen M. Hahn,…

Read MoreTurn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical and Regulatory Lead
Scribe Therapeutics

Scribe Therapeutics Showcases Enhanced CRISPR Gene Editing Data at ASGCT 2026

Scribe Therapeutics Reports Preclinical Data at ASGCT 2026 Demonstrating Enhanced Potency and Specificity of Engineered CRISPR Technologies for Epigenetic Silencing and Gene Editing Scribe Therapeutics, Inc. a biotechnology company engineering purpose-built CRISPR technologies to reshape the treatment of disease by…

Read MoreScribe Therapeutics Showcases Enhanced CRISPR Gene Editing Data at ASGCT 2026
Bojangles

Bojangles Foundation Raises $650K for Pediatric Heart Care Through Heart-Shaped Biscuit Campaign

Bojangles Foundation Raises More Than $650,000 Through Heart-Shaped Biscuits & Round-Up Campaign to Support Pediatric Heart Care and Research For the second year in a row, Bojangles and The Bojangles Foundation partnered with NFL legend Greg Olsen and The HEARTest…

Read MoreBojangles Foundation Raises $650K for Pediatric Heart Care Through Heart-Shaped Biscuit Campaign
ImmunityBio

ImmunityBio Secures Exclusive U.S. Deal with Japan BCG Laboratory to Expand Tokyo Strain BCG Supply

ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United States ImmunityBio, Inc. a commercial-stage immunotherapy company, announced an exclusive U.S. Development and Supply Agreement with Japan BCG…

Read MoreImmunityBio Secures Exclusive U.S. Deal with Japan BCG Laboratory to Expand Tokyo Strain BCG Supply

OBIO® and IPON Renew Multi-Year Partnership to Strengthen Ontario’s Sovereign IP Capacity

OBIO® and IPON Renew Multi-Year Collaboration to Advance Ontario’s Sovereign IP Capacity OBIO® and Intellectual Property Ontario (IPON) have renewed their memorandum of understanding (MOU) to ensure that Ontario’s next generation of companies developing innovative human health products continue to access optimal…

Read MoreOBIO® and IPON Renew Multi-Year Partnership to Strengthen Ontario’s Sovereign IP Capacity
Massive Bio Partners with Just Worldwide to

Massive Bio Partners with Just Worldwide to Connect More Cancer Patients with Clinical Trials

Massive Bio and Just Worldwide Announce Strategic Partnership to Connect More Cancer Patients to Clinical Trials Massive Bio, the global leader in AI-driven clinical trial matching for cancer patients, and Just Worldwide, a leading global fieldwork and market research provider…

Read MoreMassive Bio Partners with Just Worldwide to Connect More Cancer Patients with Clinical Trials
IQVIA

IQVIA and Kexing Biopharm Expand AI-Driven Collaboration to Accelerate Global Biosimilar Development

IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities IQVIA a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, is advancing its strategic…

Read MoreIQVIA and Kexing Biopharm Expand AI-Driven Collaboration to Accelerate Global Biosimilar Development
Next Health

Next Health Opens in Peoria, Bringing Advanced Longevity and Preventive Care Services to Arizona

Next Health in Peoria Hosting Grand Opening, Bringing Advanced Longevity & Preventive Health Services to Arizona Next Health, the world’s most advanced and comprehensive brand of health optimization and longevity centers, invites the community and media to its newest location in…

Read MoreNext Health Opens in Peoria, Bringing Advanced Longevity and Preventive Care Services to Arizona
Dyno Therapeutics

Dyno Therapeutics Expands Frontiers Network, Announces Second Annual GATC

Dyno Therapeutics Announces Expanded Frontiers Network and Second Annual Genetic Agency Technology Conference (GATC) Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, announced significant updates to two mission-driven initiatives:…

Read MoreDyno Therapeutics Expands Frontiers Network, Announces Second Annual GATC